文献速递腹部MR

原发性硬化性胆管炎:MRI 与血液检查及临床评分系统评估组织病理学疾病严重程度的诊断效能比较

Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

该回顾性研究纳入 51 例原发性硬化性胆管炎患者,比较 MRI 与血液检查及临床评分系统评估肝组织病理学严重程度的诊断效能。结果显示肝硬化/门静脉高压的 MRI 征象、血液检查和临床评分系统对晚期组织病理学分期诊断效能高,而 MRI 胆管异常严重程度则不然。

要点

  • 肝硬化/门静脉高压的 MRI 征象是唯一能诊断晚期 PSC(3 和 4 期)的影像特征,两名观察者 AUC 均达 0.90(p < 0.001)。
  • MRCP 整体胆管异常严重程度与组织病理学分期的相关性弱(一名观察者 r = 0.36,p = 0.01)。
  • FIB-4 指数、Child-Pugh、MELD、Mayo 风险评分、APRI 和碱性磷酸酶对晚期 PSC 分期诊断效能良好至优秀(AUC 0.672–0.915,p < 0.045)。

关键影像表现/征象

  • 肝硬化/门静脉高压的 MRI 征象是唯一能诊断晚期 PSC(3 和 4 期)的影像特征,两名观察者 AUC 均达 0.90(p < 0.001)。
  • 实质强化和整体定性胆管异常仅在一名观察者中识别晚期 PSC 分期(AUC 达 0.767,p = 0.002)。
  • MRCP 整体定性胆管异常与组织病理学分期仅在一名观察者中呈弱相关(r = 0.36,p = 0.01)。

诊断标准与关键数值

  • 两名放射科医师独立使用标准化评分系统对 MRCP 胆管异常严重程度、实质强化和 DWI 信号进行分级。
  • 组织病理学采用改良 Nakanuma 评分系统评估。
  • 肝硬化/门静脉高压征象诊断晚期 PSC(3 和 4 期)的 AUC 两名观察者均达 0.90(p < 0.001)。
  • 实质强化和整体定性胆管异常诊断晚期 PSC 的 AUC 仅一名观察者达 0.767(p = 0.002)。
  • FIB-4 指数、Child-Pugh、MELD、Mayo 风险评分、APRI 和碱性磷酸酶诊断晚期 PSC 的 AUC 为 0.672–0.915(p < 0.045)。

临床应用与阅片要点

  • 阅片时应关注肝硬化/门静脉高压的 MRI 征象,其有助于识别晚期组织病理学 PSC 分期。
  • MRCP 胆管异常严重程度与组织病理学分期的相关性弱,不宜单独用于评估组织病理学严重程度。
  • 血液检查及临床评分系统(FIB-4 指数、Child-Pugh、MELD、Mayo 风险评分、APRI、碱性磷酸酶)对晚期 PSC 分期诊断效能良好至优秀。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the diagnostic performance of magnetic resonance imaging (MRI) compared to blood tests and clinical scoring systems for the evaluation of histopathologic severity in patients with primary sclerosing cholangitis (PSC).

MATERIALS: Fifty-one patients (M/F 37/14, mean age 41 years) with PSC who underwent MRI and liver histopathology were included in this IRB-approved retrospective study. Two radiologists independently graded the severity of biliary abnormalities on magnetic resonance cholangiopancreatography (MRCP) using a standardized scoring system, parenchymal enhancement, and diffusion-weighted imaging (DWI) signal. Liver function tests, Mayo Risk score, APRI, FIB-4 Index, MELD, and Child-Pugh scores were recorded. Histopathology was assessed using a modified Nakanuma's scoring system. Correlation and diagnostic performance of MRI scores and blood tests for assessment of PSC histopathologic disease severity were evaluated.

RESULTS: Findings of cirrhosis and portal hypertension were the only imaging features diagnostic of advanced PSC (stages 3 and 4) with AUC up to 0.90 (p < 0.001) for both observers. Parenchymal enhancement and overall qualitative biliary ductal abnormality identified advanced PSC stage with AUC up to 0.767 (p = 0.002) only for one observer. There was weak correlation between the overall qualitative biliary ductal abnormality on MRCP and histopathologic stage (r = 0.36, p = 0.01) for one observer. FIB-4 index, Child-Pugh, MELD, Mayo Risk, APRI, and alkaline phosphatase demonstrated good to excellent performance for advanced PSC stage (AUCs 0.672-0.915, p < 0.045).

CONCLUSIONS: MRI findings of cirrhosis/portal hypertension, blood tests, and clinical scoring systems had high performance for advanced histopathologic PSC stage diagnosis, while the severity of biliary abnormalities on MRI did not.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Song C, Lewis S, Kamath A, et al. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease. Abdom Radiol (NY). 2020. PMID: 31844914. doi:10.1007/s00261-019-02366-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。